Nasopharyngeal Carriage of Individual Streptococcus pneumoniae Serotypes During Pediatric Pneumonia as a Means to Estimate Serotype Disease Potential

被引:76
作者
Greenberg, David [1 ]
Givon-Lavi, Noga [1 ]
Newman, Nitza [2 ]
Bar-Ziv, Jacob [3 ]
Dagan, Ron [1 ]
机构
[1] Ben Gurion Univ Negev, Pediat Infect Dis Unit, Soroka Univ Med Ctr, IL-84105 Beer Sheva, Israel
[2] Ben Gurion Univ Negev, Dept Pediat Surg, Soroka Univ Med Ctr, IL-84105 Beer Sheva, Israel
[3] Hadassah Univ Med Ctr, Dept Radiol, Jerusalem, Israel
关键词
community-acquired pneumonia; children; chest x-ray; clinical; laboratory characteristics; PNEUMOCOCCAL CONJUGATE VACCINE; ACUTE OTITIS-MEDIA; INVASIVE-DISEASE; PARAPNEUMONIC EMPYEMA; CHILDREN; IMPACT; POPULATION; EMERGENCE; DURATION; 7-VALENT;
D O I
10.1097/INF.0b013e3181f87802
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: We aimed at estimating pneumococcal serotype-specific disease potential in pediatric community-acquired alveolar pneumonia (CAAP), by comparing nasopharyngeal pneumococcal carriage during disease to carriage in healthy children. Methods: Pneumococcal nasopharyngeal cultures were obtained from children <5 years old admitted to the emergency room or hospitalized with radiologically diagnosed CAAP and from healthy controls. Disease potential was estimated by calculating serotype-specific odds ratios (OR) of a given serotype to be carried during disease compared with healthy children (after adjustment for age, ethnicity, previous antibiotic therapy, and season). Results: A total of 603 and 1504 isolates were obtained from CAAP and healthy children, respectively. A significant OR >1.0 of a specific serotype being carried during disease (suggesting a higher disease potential) was observed with serotypes (by decreasing rank) 1, 5, 22F, 7F, 14, 9V, and 19A. A significant OR <1.0 of being carried during disease (suggesting a lower disease potential) was observed with serotypes 6A, 6B, 23A, and 35B. Carriage of PCV7 serotypes (grouped) during CAAP was highest in age group 6 to 17 months. PCV10 and PCV13 provided significantly higher coverage for both 6 to 17 and 18 to 35 month age groups. Conclusions: It is suggested that serotypes 1, 5, 7F, 9V, 14, 19A, and 22F have a higher disease potential for childhood pneumonia than do serotypes 6A, 6B, 23A, and 35B.
引用
收藏
页码:227 / 233
页数:7
相关论文
共 38 条
[11]   Universal childhood immunisation against Streptococcus pneumoniae: The five-year experience of Liguria Region, Italy [J].
Durando, Paolo ;
Crovari, Pietro ;
Ansaldi, Filippo ;
Sticchi, Laura ;
Sticchi, Camilla ;
Turello, Valter ;
Marensi, Lorenzo ;
Giacchino, Raffaella ;
Timitilli, Anna ;
Carloni, Roberto ;
Azzari, Chiara ;
Icardi, Giancarlo .
VACCINE, 2009, 27 (25-26) :3459-3462
[12]   Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: Experiences from the south Swedish pneumococcal intervention project [J].
Ekdahl, K ;
Ahlinder, I ;
Hansson, HB ;
Melander, E ;
Molstad, S ;
Soderstrom, M ;
Persson, K .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (05) :1113-1117
[13]   A decade (1989-1998) of pediatric invasive pneumococcal disease in 2 populations residing in 1 geographic location: Implications for vaccine choice [J].
Fraser, D ;
Givon-Lavi, N ;
Bilenko, N ;
Dagan, R .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (04) :421-427
[14]  
GRIJALVA CG, CLIN INFECT DIS, V50, P805
[15]   Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland [J].
Hanage, WP ;
Kaijalainen, TH ;
Syrjänen, RK ;
Auranen, K ;
Leinonen, M ;
Mäkelä, PH ;
Spratt, BG .
INFECTION AND IMMUNITY, 2005, 73 (01) :431-435
[16]   Ability of pneumococcal serotypes and clones to cause acute otitis media:: Implications for the prevention of otitis media by conjugate vaccines [J].
Hanage, WP ;
Auranen, K ;
Syrjänen, R ;
Herva, E ;
Mäkelä, PH ;
Kilpi, T ;
Spratt, BG .
INFECTION AND IMMUNITY, 2004, 72 (01) :76-81
[17]   The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease [J].
Hausdorff, William P. .
VACCINE, 2007, 25 (13) :2406-2412
[18]   Multinational study of pneumococcal serotypes causing acute otitis media in children [J].
Hausdorff, WP ;
Yothers, G ;
Dagan, R ;
Kilpi, T ;
Pelton, SI ;
Cohen, R ;
Jacobs, MR ;
Kaplan, SL ;
Levy, C ;
Lopez, EL ;
Mason, EO ;
Syriopoulou, V ;
Wynne, B ;
Bryant, J .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (11) :1008-1016
[19]   FIVE-FOLD INCREASE IN PEDIATRIC PARAPNEUMONIC EMPYEMA SINCE INTRODUCTION OF PNEUMOCOCCAL CONJUGATE VACCINE [J].
Hendrickson, Debra J. ;
Blumberg, Dean A. ;
Joad, Jesse P. ;
Jhawar, Sanjay ;
McDonald, Ruth J. .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (11) :1030-1032
[20]   Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the united states during the era of widespread PCV7 vaccination, 1998-2004 [J].
Hicks, Lauri A. ;
Harrison, Lee H. ;
Flannery, Brendan ;
Hadler, James L. ;
Schaffner, William ;
Craig, Allen S. ;
Jackson, Delois ;
Thomas, Ann ;
Beall, Bernard ;
Lynfield, Ruth ;
Reingold, Arthur ;
Farley, Monica M. ;
Whitney, Cynthia G. .
JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (09) :1346-1354